scholarly article | Q13442814 |
P50 | author | Annamaria Colao | Q64495559 |
Paola Razzore | Q99552546 | ||
P2093 | author name string | E. Ghigo | |
F. Camanni | |||
M. Gasperi | |||
E. Martino | |||
M. Giusti | |||
E. Ciccarelli | |||
S. Grottoli | |||
D. Gaia | |||
V. Gasco | |||
P2860 | cites work | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women | Q30466617 | ||
Investigation protocol: acromegaly and its investigation | Q33704125 | ||
Determinants of circulating insulin-like growth factor-I. | Q33708548 | ||
Criteria for cure of acromegaly: a consensus statement | Q33848161 | ||
Nutritional regulation of the insulin-like growth factors | Q34339433 | ||
Somatotrope responsiveness to Hexarelin, a synthetic hexapeptide, is refractory to the inhibitory effect of glucose in obesity | Q38350774 | ||
Current treatment guidelines for acromegaly | Q40846028 | ||
Human growth hormone and human aging | Q40906146 | ||
Clinical review 75: Recent advances in pathogenesis, diagnosis, and management of acromegaly | Q40928588 | ||
Growth hormone, insulin-like growth factor-I and its binding proteins in the follow-up of acromegaly. | Q41656044 | ||
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucose | Q42512966 | ||
Increasing growth with raised circulating somatomedin but normal immunoassayable growth hormone | Q44514242 | ||
Acromegaly with normal fasting growth hormone concentrations but abnormal growth hormone regulation | Q44592641 | ||
Low basal and persistent pulsatile growth hormone secretion are revealed in normal and hyposomatotropic men studied with a new ultrasensitive chemiluminescence assay | Q45088930 | ||
Evaluation of Acromegaly by Radioimmunoassay of Somatomedin-C | Q46894311 | ||
Growth-hormone and prolactin excess | Q48785419 | ||
Glucose suppression of serum growth hormone in the diagnosis of acromegaly. | Q51689262 | ||
Effects of caloric or protein restriction on insulin-like growth factor-I (IGF-I) and IGF-binding proteins in children and adults. | Q55063316 | ||
Growth hormone responses to oral glucose loading measured by highly sensitive enzyme immunoassay in normal subjects and patients with glucose intolerance and acromegaly | Q67273639 | ||
Responses of growth hormone and cortisol to intravenous glucose loading test in patients with anorexia nervosa | Q68176647 | ||
Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH | Q69400476 | ||
Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion | Q69919209 | ||
Paradoxical elevation of growth hormone in active chronic hepatitis | Q70122496 | ||
The importance of insulin-like growth factor (somatomedin) measurements in the diagnosis and surveillance of acromegaly | Q70232094 | ||
Paradoxical release of growth hormone during oral glucose tolerance test in patients with abnormal glucose tolerance | Q70242739 | ||
Growth hormone pulsatility in active and cured acromegalic subjects | Q70809158 | ||
New approach to the diagnosis of growth hormone deficiency in adults | Q71046146 | ||
Characterization of 24-hour growth hormone secretion in acromegaly: implications for diagnosis and therapy | Q72106085 | ||
A comparison of different methods for diagnosing acromegaly | Q73529922 | ||
Evaluation of disease activity by IGF-I and IGF binding protein-3 (IGFBP3) in acromegaly patients distributed according to a clinical score | Q74631141 | ||
Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features | Q74631149 | ||
Evaluation of disease status with sensitive measures of growth hormone secretion in 60 postoperative patients with acromegaly | Q77549282 | ||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | endocrinology | Q162606 |
P304 | page(s) | 123-127 | |
P577 | publication date | 2003-02-01 | |
P1433 | published in | Journal of Endocrinological Investigation | Q15766847 |
P1476 | title | Three-hour spontaneous GH secretion profile is as reliable as oral glucose tolerance test for the diagnosis of acromegaly | |
P478 | volume | 26 |
Q89724347 | Acromegaly in the elderly patients |
Q44435847 | Acromegaly: Are new tests needed? |
Q42473658 | Adrenal lesions in acromegaly: do metabolic aspects and aryl hydrocarbon receptor interacting protein gene have a role? Evaluation at baseline and after long-term follow-up |
Q51493161 | Age changes the diagnostic accuracy of mean profile and nadir growth hormone levels after oral glucose in postoperative patients with acromegaly. |
Q45912383 | Biochemical diagnosis and assessment of disease activity in acromegaly: a two-decade experience. |
Q39123579 | Biochemical investigations in diagnosis and follow up of acromegaly |
Q42457597 | Clinical aspects and therapeutic outcome in thyrotropin-secreting pituitary adenomas: a single center experience |
Q38131055 | Diagnosis of acromegaly: state of the art. |
Q37140813 | Dynamic tests for the diagnosis and assessment of treatment efficacy in acromegaly |
Q46665459 | Effect of different therapeutic modalities on spontaneous GH secretion in acromegalic patients |
Q83351941 | Effects of arginine treatment on nutrition, growth and urea cycle function in seven Japanese boys with late-onset ornithine transcarbamylase deficiency |
Q33739766 | Growth hormone nadir during oral glucose load depends on waist circumference, gender and age: normative data in 231 healthy subjects |
Q87888644 | Safety and specificity of the growth hormone suppression test in patients with diabetes |
Q42654837 | The R304X mutation of the aryl hydrocarbon receptor interacting protein gene in familial isolated pituitary adenomas: Mutational hot-spot or founder effect? |
Search more.